Coming in January 2010
Chimerism
Volume 1, Issue 1January/February/March 2010
Submit your paper to Chimerism
Chimerism will utilize an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.
We will begin accepting submissions in June 2009.
Call for Papers
Editor-in-Chief
J. Lee Nelson
Fred Hutchinson Cancer Research Center
University of Washtington
Seattle, WA
Co-Editor
Will Burlingham
University of Wisconsin Schoool of Medicine & Public Health
Madison, WI
Email the Managing Editor.
Online ISSN: 1938-1964 DOI: 10.4161/chim
About the journal
The mission of Chimerism is to disseminate high quality scientific work that provides novel insights into the spectrum of chimerism in human health and disease, both beneficial and adverse effects. The journal is highly interdisciplinary providing a forum of exchange for studies of naturally acquired chimerism as well as iatrogenic chimerism, the latter in transplantation and transfusion.
Chimerism is of special interest to physicians, scientists, and other investigators in transplantation, transfusion, maternal-fetal medicine, genetics, immunology, cancer and infectious diseases.
The readership of Chimerism is anticipated to include M.D. and Ph.D. scientists as well as other professional personnel.
Why publish in Chimerism?
It's time for Chimerism
There are a number of reasons why this is an ideal time to launch the new journal Chimerism. First, advances in molecular biological techniques over the past 10 years have resulted in tools to measure and characterize Mc that were previously unavailable. Also, it has only recently been appreciated that cells routinely traffic between the mother and fetus and that some cells persist decades later in respective individuals. Early studies suggest naturally acquired Mc has both detrimental and adverse consequences. A forum for interdisciplinary exchange is especially timely as investigators stand to profit by knowledge from colleagues in other research areas. For example, prior transplantation Mc studies generally tested female recipients of male grafts for male DNA, but were done prior to appreciation of persistent fetal Mc. Another example is shared insights may be garnered from pregnancy immunology (tolerance of the genetically disparate fetus) and transplantation (allograft) tolerance. Finally, another reason the time is ideal to launch Chimerism is the need to establish standard techniques and measures of chimerism that are shared across disciplines as well as internationally.
